Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: How reliable, consistent, and meaningful is the effect?

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 1, 2006, Pages 135-141

  Siker, Malika L ^a   Tomé, Wolfgang A ^a   Mehta, Minesh P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Helical tomotherapy; Intensity modulated radiation therapy; Lung cancer response rates; Megavoltage CT; Non small cell lung cancer

Indexed keywords

ESCALATORS; NETWORK PROTOCOLS; PATIENT MONITORING; REGRESSION ANALYSIS; TOMOGRAPHY; TUMORS;

HELICAL TOMOTHERAPY; INTENSITY-MODULATED RADIATION THERAPY; LUNG CANCER RESPONSE RATES; MEGAVOLTAGE CT; NON-SMALL-CELL LUNG CANCER;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; MEGAVOLTAGE RADIATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RADIOSURGERY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TOMOTHERAPY HI ART SYSTEM; TUMOR REGRESSION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; STEREOTAXIC TECHNIQUES; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 33746814036     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.03.064     Document Type: Article

References (16)

1. Welsh J.S., Bradley K., Ruchala K.J., et al. Megavoltage computed tomography imaging. A potential tool to guide and improve the delivery of thoracic radiation therapy. Clin Lung Cancer 5 (2004) 303-306
2. Erridge S.C., Seppenwoolde Y., Muller S.H., et al. Portal imaging to assess set-up errors, tumor motion, and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. Radiother Oncol 66 (2003) 75-85
3. Kupelian P.A., Ramsey C., Meeks S.L., et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer. Observations on tumor regression during treatment. Int J Radiat Oncol Biol Phys 63 (2005) 1024-1028
4. Fuss M., Salter B.J., Rassiah P., et al. Repositioning accuracy of a commercially available double vacuum whole body immobilization system for stereotactic body radiotherapy. Technol Cancer Res Treat 3 (2004) 59-67
5. Zhang T., Orton N.P., and Tomé W.A. On the automated definition of mobile target volumes from 4D-CT images for stereotactic body radiotherapy. Med Phys 32 (2005) 3493-3502
6. Thompson D. On growth and form. abridged ed. (1961), Cambridge University Press, New York
7. Chappell R.J., Miranpuri S.S., and Mehta M.P. The importance of dimension in defining tumor response. J Clin Oncol 16 (1998) 1234
8. Miranpuri S.S., Schulz C.A., Chappell R.J., et al. Comparison of methods for response analysis of central nervous system neoplasms. J Radiosurg 2 (1999) 153-162
9. Dar A.R., Yartsev S., Rodrigues G., et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer. In regard to Kupelian, et al. Int J Radiat Oncol Biol Phys 64 (2006) 328
10. Kupelian P.A., Ramsey C., Meeks S.L., et al. In response to Dr. Dar, et al. Int J Radiat Oncol Biol Phys 64 (2006) 328-329
11. Perez C.A., Stanley K., Rubin P., et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. preliminary report by the Radiation Therapy Oncology Group. Cancer 45 (1980) 2744-2753
12. Tannehill S.P., Mehta M.P., Larson M., et al. Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small cell lung cancer. Results of a phase II trial. J Clin Oncol 15 (1997) 2850-2857
13. Blanke C., Ansari R., Mantravadi R., et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer. A Hoosier Oncology Group protocol. J Clin Oncol 13 (1995) 1425-1429
14. Belani C.P., Wang W., Johnson D.H., et al. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597). Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer. J Clin Oncol 23 (2005) 3760-3767
15. Giraud P., Antoine M., Larrouy A., et al. Evaluation of microscopic tumor extension in non-small cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Biol Phys 48 (2000) 1015-1024
16. Fitch D.L., Goldstein N.S., Yan D., et al. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma. Implications for defining the clinical target volume (CTV) for radiotherapy. [Abstract]. Int J Radiat Biol Phys 63 Suppl. 1 (2005) S99-S100